Yifan Pharmaceutical Co., Ltd. (SHE: 002019)
China
· Delayed Price · Currency is CNY 10.69
-0.11 (-1.02%)
Feb 6, 2025, 10:30 AM CST
Yifan Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 5, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 13,137 | 18,014 | 15,019 | 21,745 | 23,372 | 17,082 | Upgrade
|
| Market Cap Growth | -7.91% | 19.94% | -30.93% | -6.96% | 36.83% | 32.27% | Upgrade
|
| Enterprise Value | 14,468 | 19,400 | 16,499 | 22,717 | 23,710 | 17,640 | Upgrade
|
| Last Close Price | 10.80 | 14.64 | 12.13 | 17.45 | 18.70 | 15.97 | Upgrade
|
| PE Ratio | - | - | 78.54 | 78.11 | 24.14 | 18.91 | Upgrade
|
| Forward PE | 26.02 | 7.82 | 7.82 | 7.82 | 7.82 | 7.82 | Upgrade
|
| PS Ratio | 2.64 | 4.43 | 3.91 | 4.93 | 4.33 | 3.29 | Upgrade
|
| PB Ratio | 1.54 | 2.18 | 1.64 | 2.48 | 2.68 | 2.18 | Upgrade
|
| P/TBV Ratio | 3.87 | 4.67 | 2.82 | 4.23 | 4.70 | 4.21 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 59.50 | 240.02 | Upgrade
|
| P/OCF Ratio | 34.61 | 51.68 | 31.82 | 72.19 | 21.08 | 18.23 | Upgrade
|
| EV/Sales Ratio | 2.90 | 4.77 | 4.30 | 5.15 | 4.39 | 3.40 | Upgrade
|
| EV/EBITDA Ratio | 32.44 | 72.38 | 43.52 | 50.06 | 19.91 | 14.47 | Upgrade
|
| EV/EBIT Ratio | 95.61 | 926.80 | 96.29 | 86.48 | 23.38 | 16.56 | Upgrade
|
| EV/FCF Ratio | -194.45 | - | - | - | 60.36 | 247.87 | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.24 | 0.24 | 0.26 | 0.19 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 5.62 | 6.97 | 5.44 | 4.84 | 1.39 | 1.57 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 4.23 | 26.87 | Upgrade
|
| Asset Turnover | 0.40 | 0.34 | 0.31 | 0.37 | 0.48 | 0.50 | Upgrade
|
| Inventory Turnover | 2.65 | 2.43 | 2.65 | 4.16 | 4.91 | 5.22 | Upgrade
|
| Quick Ratio | 0.89 | 0.94 | 1.19 | 1.13 | 1.22 | 0.93 | Upgrade
|
| Current Ratio | 1.32 | 1.49 | 1.68 | 1.56 | 1.65 | 1.22 | Upgrade
|
| Return on Equity (ROE) | -7.68% | -10.18% | 1.42% | 2.77% | 11.25% | 11.87% | Upgrade
|
| Return on Assets (ROA) | 0.77% | 0.11% | 0.87% | 1.38% | 5.58% | 6.39% | Upgrade
|
| Return on Capital (ROIC) | 0.86% | 0.12% | 0.96% | 1.53% | 6.30% | 7.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.61% | 0.22% | 1.66% | 2.66% | 10.66% | 13.02% | Upgrade
|
| Earnings Yield | -2.52% | -3.06% | 1.27% | 1.28% | 4.14% | 5.29% | Upgrade
|
| FCF Yield | -0.57% | -0.86% | -0.47% | -1.24% | 1.68% | 0.42% | Upgrade
|
| Dividend Yield | 1.85% | - | - | - | 0.27% | 0.63% | Upgrade
|
| Payout Ratio | 0.00% | - | 45.18% | 49.71% | 20.86% | 21.29% | Upgrade
|
| Buyback Yield / Dilution | 1.37% | 3.94% | -5.32% | 1.25% | -0.40% | -0.99% | Upgrade
|
| Total Shareholder Return | 3.23% | 3.94% | -5.32% | 1.25% | -0.13% | -0.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.